<DOC>
	<DOCNO>NCT00907374</DOCNO>
	<brief_summary>The objective study assess effect standard versus aggressive inhibition renin-angiotensin system ( RAS ) type 2 diabetic patient microalbuminuria ( MA ) ; ) progression microalbuminuria , b ) estimate glomerular filtration rate ( eGFR ) , c ) endothelial dysfunction ( measure post-hyperemia arterial tonometry ) ) slow progression atherosclerotic disease ( measure carotid intima medium thickness [ CIMT ] ) .</brief_summary>
	<brief_title>Low Dose Versus Aggressive Inhibition Renin-Angiotensin-Aldosterone ( RAS ) Treat Microalbuminuria</brief_title>
	<detailed_description>Diabetic patient confirm MA ( 50-300 mg albumin per g creatinine ) morning spot urine sample enter one three month run-in phase randomization . ( 50 mg/g use low limit allow room improvement reach normal . ) Since hypertension uncontrolled hyperglycemia cause MA , blood pressure ( BP ) hemoglobin A1c ( AIC ) level reduce &lt; 130/80 mm Hg &lt; 8.0 % , respectively , period . All patient various dos angiotensin convert enzyme inhibitor ( ACE-I ) reduce 10 mg benazepril BP control class anti-hypertensive drug ( except angiotensin receptor blocker [ ARB 's ] ) . Glycemia treat intensification current therapy . MA BP measure monthly . When goal level BP AIC achieve MA still present , patient randomize either low dose RAS inhibition ( 10 mg benazepril ) ( Standard ) aggressive inhibition RAS ( Aggressive ) . MA continue measure monthly progressive increase dose ACE-I ARB follow . Benazepril ( ACE-I ) - 10 mg 20 mg 40 mg add losartan ( ARB ) -25 mg 50 mg 100 mg increase benazepril 80 mg goal return albumin excretion normal . Other class drug reduce necessary keep systolic BP &gt; 100 mm Hg . Serum creatinine potassium [ K+ ] measure monthly , AIC level every 3 month CIMT ultrasound endothelial function post hyperemia nitroglycerine ( NTG ) - induced peripheral artery tonometry ( PAT ) via finger plethysmography every six month .</detailed_description>
	<mesh_term>Albuminuria</mesh_term>
	<mesh_term>Benazepril</mesh_term>
	<criteria>Males female , age 1870 Subjects diabetic renal disease define spot urine albumin creatinine ratio 30300mg/g estimate glomerular filtration rate &gt; 60 ml/min Intake nonsteroidal antiinflammatory agent ( NSAIDs ) 15 days/month , exclude aspirin . Inability discontinue NSAIDs aspirin 5 day prior GFR measurement . History severe adverse reaction randomize drug require use protocol contraindication use . Participation another intervention study . Pregnancy likelihood become pregnant study period ; lactation Clinical laboratory evidence renal disease diabetic nephropathy . History drug abuse past 2 year , include narcotic , cocaine alcohol ( &gt; 21 drink per week ) . Serious systemic disease might influence survival course renal disease . ( Chronic oral steroid therapy exclusion , steroidcontaining nasal spray . Inactive sarcoidosis exclusion ) . History malignant accelerate hypertension within 6 month prior study entry ; previous chronic peritoneal hemodialysis renal transplantation . Known secondary cause hypertension . Spot urine albumin creatinine ratio exceed 300 ( mg/g ) Serum potassium level &gt; 5.5 mEq/L ACE inhibitor Baseline , serum potassium level &gt; 5.9 mEq/L ACE inhibitor Baseline . Leukopenia &lt; 2,500/mm3 screening confirm end Baseline . Doubt participant able adhere medication comply protocol visit schedule Arm Circumference &gt; 52 cm , precludes measure blood pressure `` thigh '' blood pressure cuff . Arm length cuff circumference extend antecubital space cuff interfere placement stethoscope brachial artery blood pressure measurement Clinical evidence lead intoxication . Clinical evidence congestive heart failure , current within precede six month . Ejection fraction 35 % measure method . Heart block great first degree arrhythmia contraindicate use primary BP drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Microalbuminuria</keyword>
	<keyword>Carotid intima medium thickness</keyword>
	<keyword>Endothelial dysfunction</keyword>
	<keyword>Renin angiotensin system</keyword>
	<keyword>Diabetic nephropathy</keyword>
</DOC>